Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.

Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, Hadadi A, Montazeri M, Nasiri M, Shirvani A, Holick MF

Open source

DOI: 10.1371/journal.pone.0239799
Published: 2020
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0239799,
  title = {Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.},
  author = {Maghbooli Z and Sahraian MA and Ebrahimi M and Pazoki M and Kafan S and Tabriz HM and Hadadi A and Montazeri M and Nasiri M and Shirvani A and Holick MF},
  year = {2020},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0239799},
  url = {https://doi.org/10.1371/journal.pone.0239799}
}

RIS

TY  - JOUR
TI  - Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
AU  - Maghbooli Z
AU  - Sahraian MA
AU  - Ebrahimi M
AU  - Pazoki M
AU  - Kafan S
AU  - Tabriz HM
AU  - Hadadi A
AU  - Montazeri M
AU  - Nasiri M
AU  - Shirvani A
AU  - Holick MF
PY  - 2020
JO  - PloS one
DO  - 10.1371/journal.pone.0239799
UR  - https://doi.org/10.1371/journal.pone.0239799
ER  -

APA

Z, M., MA, S., M, E., M, P., S, K., HM, T., A, H., M, M., M, N., A, S., & MF, H. (2020). Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.. PloS one. https://doi.org/10.1371/journal.pone.0239799

Source records

pubmed · retrieved 2026-09-25T06:27:44.212Z